• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Corcept Therapeutics Incorporated (CORT)

    -NasdaqCM
    3.16 Down 0.04(1.25%) Dec 19, 4:00PM EST
    |After Hours : 3.16 0.00 (0.00%) Dec 19, 4:48PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 10,357   3,307   -  
    Cost of Revenue143  91   -  
    Gross Profit 10,214   3,216   -  
    Operating Expenses
    Research Development20,470  14,074  21,001  
    Selling General and Administrative31,240  25,414  11,331  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (41,496) (36,272) (32,332)
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -  3  
    Earnings Before Interest And Taxes(41,496)(36,272)(32,329)
    Interest Expense4,515  1,776  25  
    Income Before Tax(46,011)(38,048)(32,354)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(46,011)(38,048)(32,354)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (46,011) (38,048) (32,354)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (46,011) (38,048) (32,354)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.